Net Assets for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported net assets is $18.47B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$18.47B
YoY change
+13.1%
5Y CAGR
-13.4%
Peak year (2019)
$51.60B
Latest annual
$18.47B
Net Assets history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Net Assets history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $18.47B | +13.1% | ||
| 2024 | $16.34B | -44.5% | ||
| 2023 | $29.43B | -5.3% | ||
| 2022 | $31.06B | -13.6% | ||
| 2021 | $35.95B | -5.0% | ||
| 2020 | $37.82B | -26.7% | ||
| 2019 | $51.60B | +267.7% | ||
| 2018 | $14.03B | +19.5% | ||
| 2017 | $11.74B | -27.4% | ||
| 2016 | $16.18B | +13.4% | ||
| 2015 | $14.27B | -3.9% | ||
| 2014 | $14.85B | -2.0% | ||
| 2013 | $15.15B | +11.2% | ||
| 2012 | $13.62B | -14.6% | ||
| 2011 | $15.96B | +1.5% | ||
| 2010 | $15.71B | +5.9% | ||
| 2009 | $14.84B | +21.3% | ||
| 2008 | $12.24B | +15.9% | ||
| 2007 | $10.56B | +5.7% | ||
| 2006 | $9.99B | -10.9% | ||
| 2005 | $11.21B | +9.9% | ||
| 2004 | $10.20B | +4.3% | ||
| 2003 | $9.79B | +11.8% | ||
| 2002 | $8.76B | -3.5% | ||
| 2001 | $9.07B | -1.1% | ||
| 2000 | $9.18B | +6.2% | ||
| 1999 | $8.64B | +14.1% | ||
| 1998 | $7.58B | +4.9% | ||
| 1997 | $7.22B | +9.9% | ||
| 1996 | $6.57B | +12.8% | ||
| 1995 | $5.82B | +2.1% | ||
| 1994 | $5.70B | -4.0% | ||
| 1993 | $5.94B | -1.3% | ||
| 1992 | $6.02B | +3.9% | ||
| 1991 | $5.79B | +7.0% | ||
| 1990 | $5.42B | +6.6% | ||
| 1989 | $5.08B | +2.7% | ||
| 1988 | $4.95B | +4.1% | ||
| 1987 | $4.75B | — |
Net Assets values are taken from Bristol-Myers Squibb's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Bristol-Myers Squibb (BMY) most recent annual net assets stands at $18.47B (2025) – grew 13.1% year-over-year.
Across 2020–2025 (5 years), Bristol-Myers Squibb net assets produced a CAGR of -13.4% – with a net decline across the window.
Between 2019 and 2025, Bristol-Myers Squibb net assets plunged 64.2%, falling from $51.60B to $18.47B.
Across the available history, net assets reached its high of $51.60B in 2019 and its low of $4.75B in 1987.
Among 8 Healthcare peers, Bristol-Myers Squibb (BMY) ranks 7th; the peer median for net assets is $50.64B.
Bristol-Myers Squibb Net Assets by Year
Bristol-Myers Squibb Net Assets 2025: $18.47B
Bristol-Myers Squibb net assets in 2025 was $18.47B, grew 13.1% from 2024.
Bristol-Myers Squibb Net Assets 2024: $16.34B
Bristol-Myers Squibb net assets in 2024 was $16.34B, plunged 44.5% below 2023.
Bristol-Myers Squibb Net Assets 2023: $29.43B
Bristol-Myers Squibb net assets in 2023 was $29.43B, declined 5.3% below 2022.
Bristol-Myers Squibb Net Assets 2022: $31.06B
Bristol-Myers Squibb net assets in 2022 was $31.06B, declined 13.6% below 2021.
Bristol-Myers Squibb Net Assets 2021: $35.95B
Bristol-Myers Squibb net assets in 2021 was $35.95B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Net Assets
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's net assets?
- Latest reported net assets for Bristol-Myers Squibb (BMY) is $18.47B (period ending December 31, 2025).
How has Bristol-Myers Squibb net assets changed year-over-year?
- Bristol-Myers Squibb (BMY) net assets changed +13.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb net assets?
- Bristol-Myers Squibb (BMY) net assets compound annual growth rate is -13.4% over the most recent 5 years available.
When did Bristol-Myers Squibb net assets hit its highest annual value?
- Bristol-Myers Squibb net assets reached its highest annual value of $51.60B in 2019.
What was Bristol-Myers Squibb net assets in 2024?
- Bristol-Myers Squibb (BMY) net assets in 2024 was $16.34B.
What was Bristol-Myers Squibb net assets in 2025?
- Bristol-Myers Squibb (BMY) net assets in 2025 was $18.47B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.